首页 > 市场调查报告书 > 医疗设备

生物材料

医用塑胶市场规模、份额和成长分析（按类型、应用、製程和地区划分）—产业预测，2026-2033年

市场调查报告书

商品编码

1901938

医用塑胶市场规模、份额和成长分析（按类型、应用、製程和地区划分）—产业预测，2026-2033年

Medical Plastics Market Size, Share, and Growth Analysis, By Type (Standard Plastics, Engineering Plastics), By Application (Medical disposables, Prosthetics), By Process, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，医用塑胶市场规模将达到 540.4 亿美元，到 2025 年将达到 582.6 亿美元，到 2033 年将达到 1062.4 亿美元，预测期（2026-2033 年）的复合年增长率为 7.8%。

医用塑胶领域以用途广泛的热塑性化合物为特征，在医疗产业投资不断增长和消费者健康意识日益增强的推动下，正经历强劲增长。医用级聚合物，例如聚碳酸酯、聚丙烯和聚乙烯，是製造关键医疗设备（包括手术导管）的必需材料。由于可支配收入的增加和生活方式的改变，预计医用塑胶的需求将显着增长。儘管在疫情相关的社交限制期间销售额曾一度下降，但该领域展现出了韧性，尤其是在一次性个人防护设备（PPE）需求激增的情况下。在医疗技术的不断进步和消费者对一次性医疗产品偏好转变的推动下，预计整体市场成长动能将持续。

医用塑胶市场驱动因素

全球医疗保健产业的显着扩张是推动医用塑胶市场前景乐观的关键因素之一。持续的全球健康挑战正在推动医疗环境中对一次性医用塑胶製品和各种耗材的需求。这种需求的激增凸显了医疗程序中对这些材料在安全、卫生和效率方面的依赖。随着医疗机构不断适应变化，医用塑胶的重要性日益凸显，推动着该行业的创新和成长，以满足医护人员和患者日益增长的需求。

医用塑胶市场的限制因素

医疗塑胶市场的成长正受到环境污染和日益恶化的废弃物管理问题的限制。随着人口成长，对塑胶製品的需求不断增加，塑胶产量也持续成长。这种快速增长不仅导致塑胶废弃物显着增加，也加剧了环境污染。这些因素为产业发展带来了巨大挑战，因为治理环境破坏和改进废弃物处理方法的努力往往与医疗领域不断增长的生产需求相衝突。因此，如何在市场成长和永续性之间取得平衡仍然是关键阻碍因素。

医用塑胶市场趋势

医用塑胶市场目前呈现价格波动与稳定性并存的趋势。原料成本的波动，尤其是原油价格的波动，正在影响聚氯乙烯（PVC）、聚乙烯（PE）、聚丙烯（PP）和聚苯乙烯（PS）等关键聚合物的价格。生产设施的产能扩张和收缩，以及中国等主要市场产能过剩的加剧，进一步影响了全球原料的供应和价格，加剧了这种波动。随着医疗需求的增长，市场正在寻求创新解决方案来应对这些挑战，并确保医用塑胶产品的品质和供应稳定。

标准塑胶
聚氯乙烯（PVC）
聚烯（PE）
聚丙烯（PP）
聚苯乙烯（PS）
聚甲基丙烯酸甲酯（PMMA）
工程塑料
聚酰胺（PA）
丙烯腈丁二烯苯乙烯（ABS）
聚碳酸酯（PC）
聚甲醛
其他的
高性能塑胶（HPP）
聚醚醚酮（PEEK）
聚四氟乙烯（PTFE）
聚苯砜（PPSU）
其他高性能塑料
硅酮
其他的
热可塑性橡胶（TPE）
热塑性聚氨酯（TPU）
可生物降解聚合物
聚合物共混物和合成橡胶

全球医用塑胶市场规模（按应用领域及复合年增长率划分）（2026-2033 年）

医用抛弃式产品
一般一次性用品
医疗包
导管
注射器
义肢
矫正器具
植入
医疗设备和器械
手术器械
诊断设备和装置
牙科器械
药物输送
其他的

全球医用塑胶市场规模（按工艺和复合年增长率划分）（2026-2033 年）

挤出成型
射出成型
吹塑成型
其他的

全球医用塑胶市场规模（按地区划分）及复合年增长率（2026-2033 年）

北美洲
- 美国
- 加拿大
欧洲
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Rochling SE & Co. KG
Nolato AB
Saint-Gobain
SABIC
Eastman Chemical Company
Dow, Inc.
Solvay SA
HMC Polymers Company Limited
ARAN BIOMEDICAL TEORANTA
Avantor, Inc.
Trinseo
Evonik Industries AG
BASF
Covestro
Arkema
Mitsubishi Chemical Corporation

结论与建议

简介目录

Product Code: SQMIG15E2132

Medical Plastics Market size was valued at USD 54.04 Billion in 2024 and is poised to grow from USD 58.26 Billion in 2025 to USD 106.24 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The medical plastics sector, characterized by versatile thermoplastic compounds, is seeing robust growth driven by heightened investments in healthcare and increased consumer health awareness. Medical-grade polymers, such as polycarbonate, polypropylene, and polyethylene, are crucial for manufacturing vital medical devices, including surgical tubing. As disposable income rises and lifestyles evolve, the demand for medical plastics is expected to expand significantly. Although there was a temporary dip in sales during earlier pandemic-related societal restrictions, the sector has shown resilience, particularly with the surge in demand for disposable personal protective equipment. Overall, the market momentum is set for continued growth, underpinned by ongoing advancements in medical technology and evolving consumer preferences towards disposable medical products.

Top-down and bottom-up approaches were used to estimate and validate the size of the Medical Plastics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Medical Plastics Market Segments Analysis

Global Medical Plastics Market is segmented by Type, by Product, by Application, by Process and by Region. Based on Type, the market is segmented into Standard Plastics, Engineering Plastics, High Performance Plastic (HPP), Silicone, and Others. Based on Application, the market is segmented into Medical disposables, Prosthetics, Medical Instruments & Tools, Drug Delivery, and Others. Based on Process, the market is segmented Extrusion, Injection Molding, Blow Molding, Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Medical Plastics Market

A key factor contributing to the positive outlook of the medical plastics market is the substantial expansion of the medical sector worldwide. The ongoing global health challenges have led to a heightened demand for single-use medical plastics and various consumables within healthcare environments. This surge in need emphasizes the reliance on these materials for safety, hygiene, and efficiency in medical practices. As healthcare facilities adapt to evolving circumstances, the importance of medical plastics becomes increasingly apparent, fostering innovation and growth in this sector to meet the rising demands of medical professionals and patients alike.

Restraints in the Medical Plastics Market

The growth of the medical plastics market is hampered by environmental pollution and the escalating issue of waste management. As the human population continues to grow, there is a heightened demand for plastic products, leading to an ongoing surge in plastic production. This upsurge not only contributes to a significant increase in plastic waste but also exacerbates environmental pollution. These factors pose considerable challenges to the industry's advancement, as efforts to combat environmental harm and improve waste disposal methods are often at odds with the rising production demands in the medical sector. Thus, the balance between market growth and sustainability remains a critical restraint.

Market Trends of the Medical Plastics Market

The Medical Plastics market is currently observing a trend marked by both stability and price volatility. Fluctuations in raw material costs, particularly due to oil price changes, are affecting the pricing dynamics of key polymers like Polyvinyl Chloride (PVC), Polyethylene (PE), Polypropylene (PP), and Polystyrene (PS). This volatility is exacerbated by capacity expansions and contractions within production facilities, alongside rising overproduction in critical markets such as China, which influences global raw material supply and prices. As healthcare demands rise, the market is navigating these challenges while striving for innovative solutions to ensure consistent quality and availability of medical plastic products.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Value Chain Analysis
Case Study Analysis
Customer & Buying Criteria Analysis
PESTEL Analysis
Macro-Economic Indicators
Market Attractiveness Index
Raw Material Analysis
Supply Chain Analysis
Pricing Analysis

Global Medical Plastics Market Size by Type & CAGR (2026-2033)

Standard Plastics
Polyvinyl Chloride (PVC)
Polyolefin (PE)
Polypropylene (PP)
Polystyrene (PS)
Poly (Methyl Methacrylate) (PMMA)
Engineering Plastics
Polyamide (PA)
Acrylonitrile Butadiene Styrene (ABS)
Polycarbonate (PC)
Polyacetal
Others
High Performance Plastic (HPP)
Polyetheretherketone (PEEK)
Polytetrafluoroethylene (PTFE)
Polyphenylsulfone (PPSU)
Other HPPS
Silicone
Others
Thermoplastic Elastomer (TPE)
Thermoplastic Polyurethane (TPU)
Biodegradable Polymers
Polymer Blends and Synthetic Rubber

Global Medical Plastics Market Size by Application & CAGR (2026-2033)

Medical Disposables
General Disposables
Medical Bags
Catheters
Syringes
Prosthetics
Limb Prosthesis
Implants
Medical Instruments & Tools
Surgical Instruments
Diagnostic Instruments & Devices
Dental Tools
Drug Delivery
Others

Global Medical Plastics Market Size by Process & CAGR (2026-2033)

Extrusion
Injection Molding
Blow Molding
Other

Global Medical Plastics Market Size by Region & CAGR (2026-2033)

North America, (by Type, by Application, by Process)
- US
- Canada
Europe, (by Type, by Application, by Process)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (by Type, by Application, by Process)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (by Type, by Application, by Process)
- Brazil
- Rest of Latin America
Middle East & Africa, (by Type, by Application, by Process)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Rochling SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nolato AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Saint-Gobain
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SABIC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eastman Chemical Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dow, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solvay S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HMC Polymers Company Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ARAN BIOMEDICAL TEORANTA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avantor, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinseo
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evonik Industries AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BASF
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covestro
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arkema
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mitsubishi Chemical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments